Genesis Therapeutics has secured $200 million funding from NVentures, NVIDIA’s venture capital arm. This forms part of an ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

Pharmacokinetic (PK) tests form an integral part of the drug development process, helping to ensure the safety and efficacy ...

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are ...

Medable recently introduced AI features within its clinical trial platform, Medable Studio, aimed at accelerating digital and ...

A recent Lindus Health survey emphasizes the importance of patient-centered designs in clinical trials, particularly ...

Gifthealth Partners with United Digestive to boost patient access and procedure prep. Gifthealth has announced a strategic ...

Rogers, chief scientific officer at Coronado Research, she shares insights on the evolving landscape of pharmaceutical ...

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

Abbisko’s small molecule drug pimicotinib has smashed the primary goal of a phase 3 trial for the treatment of tenosynovial ...